Smart Insulin Pen Market Set to Exhibit 4.2% Growth By 2031 Amid Rising Prevalence of Diabetes
![]() |
Smart Insulin Pen Market |
Market Overview
The smart
insulin pen market has been gaining significant traction over the recent past
owing to the growing prevalence of diabetes. Smart insulin pens integrate both
insulin delivery devices as well as glucose monitoring systems to deliver the
right insulin dose as per the observed glucose levels. The smart connected pens
help in tracking insulin usage and dosing patterns. They offer accurate dosing
along with connectivity apps to share data with healthcare professionals.
The Global Smart Insulin Pen Market is estimated to be
valued at US$ 50.58 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period
2024 to 2031.
Key Takeaways
Key players operating in the Smart
Insulin Pen Market Size are Bayer AG, Henkel AG & Co. KgaA, Avon
Products Inc., Johnson & Johnson Inc., Kao Corporation, Beiersdorf AG,
Groupe Clarins SA, Revlon Inc., Shiseido Co. Ltd., Unilever PLC, Procter &
Gamble, L'Oréal SA, Lotus Herbals Pvt. Ltd., and The Estée Lauder Companies
Inc., among others. The increasing adoption of connected health solutions
across the world presents significant opportunities for players in the smart
insulin pen market. Major players are focusing on expanding their geographical
presence in emerging markets like Asia Pacific and Latin America.
The growing diabetic patient pool worldwide along with increasing healthcare
expenditures provides a huge market potential for smart insulin pen
manufacturers. Rapid urbanization and changing lifestyles have contributed to
the growing prevalence of diabetes. However, the high cost of smart insulin
pens compared to conventional versions remains a key market restraint. Lack of
reimbursement coverage in some countries further hampers the adoption of smart
connected insulin pens.
Market Drivers
The key driver for the smart insulin pen market is the growing prevalence
of diabetes. As per estimates, around 463 million people had diabetes in 2019
globally and the number is expected to rise to 700 million by 2045. Another
major driver is the increasing healthcare expenditures in emerging economies
which is enabling more widespread adoption of smart connected health solutions.
Market Restraints
However, the high cost of smart insulin pens compared to conventional
disposable pens remains a key market restraint. While smart connected pens
offer valuable dosing and usage insights, the higher price point limits their
adoption in price-sensitive regions. Additionally, lack of reimbursement
coverage for smart insulin pens in some developing markets further challenges
their demand and large-scale commercialization.
Segment Analysis
Smart insulin pens hold the major market share currently as they provide
ease of use and convenient dosing of insulin. With rising prevalence of
diabetes, self-injection devices are rapidly gaining acceptance among
consumers. Smart insulin pens are preferred for their ability to automatically
calculate and deliver accurate doses of insulin as prescribed by physicians.
Subcutaneous injection remains the most common mode of insulin administration
and smart insulin pens enable simple and discreet subcutaneous injection. Their
integration with smartphone apps allows remote monitoring of dosing history and
insulin on board which helps achieve better glycemic control. This has made
smart insulin pens the dominating sub segment currently.
Global Analysis
North America accounts for the largest share in the smart insulin pen
market due to high acceptance of digital health technologies and growing
diabetic population in the US and Canada. Favorable reimbursement policies and
insurance coverage for innovative diabetes management solutions also
contributes to the leading position of North America region. The Asia Pacific
region is expected to witness fastest growth during the forecast period owing
to increasing healthcare investments, growing economy and rapidly aging
population susceptible to diabetes in China and India. Rising awareness
regarding advantages of smart insulin pens over conventional syringes and pens
will further augment the regional market over the next few years.
Get more insights on Smart
Insulin Pen Market
Comments
Post a Comment